An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina

Brain Research

Volumn 877, Issue 1, 2000, Pages 47-57

  Chao, H M ^a   Chidlow, G ^a   Melena, J ^a   Wood, J P M ^a   Osborne, N N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Basic fibroblast growth factor; Betaxolol; Calcium channel; Clonidine; Lipid peroxidation; Neuroprotection; Reactive oxygen species; Sodium channel; 2 Adrenoceptor agonist

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; BETAXOLOL; CALCIUM CHANNEL; CLONIDINE; N METHYL DEXTRO ASPARTIC ACID; REACTIVE OXYGEN METABOLITE; SODIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; CALCIUM TRANSPORT; CELL DEATH; CONTROLLED STUDY; DRUG ANTAGONISM; LIGAND BINDING; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; RETINA; RETINA GANGLION CELL;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BATRACHOTOXINS; BETAXOLOL; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; CHICK EMBRYO; CLONIDINE; FIBROBLAST GROWTH FACTOR 2; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRENDIPINE; RABBITS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RETINA; RNA, MESSENGER; SAXITOXIN; SODIUM CHANNELS;

EID: 0034665931     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02592-0     Document Type: Article

References (58)

1. Berkman M.Z., Zirh T.A., Berkman K., Pamir M.N. Tizanidine is an effective agent in the prevention of focal cerebral ischaemia in rats: an experimental study. Surg. Neurol. 50:1998;264-270.
2. Berlie J.R., Iversen L.J., Blaxall H.S., Cooley M.E., Chacko D.M., Bylund D.B. Alpha-2 adrenergic receptors in the bovine retina: Presence of only the alpha-2D subtype. Invest. Ophthalmol. Vis. Sci. 36:1995;1885-1892.
3. Bertolino M., Vicini S., Gillis R., Travagli A. Presynaptic alpha2-adrenoceptors inhibit excitatory synaptic transmission in rat brain stem. Am. J. Physiol. 272:1997;G654-661.
4. Bickler P.E., Hansen B.M. Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia. Neuropharmacology. 35:1996;679-687.
5. Bittiger H., Heid J., Wigger N. Are only alpha-2-adrenergic receptors present in bovine retina? Nature. 287:1980;645-647.
6. Bylund D.B., Chacko D.M. Characterization of alpha-2 adrenergic receptor subtypes in human ocular tissue homogenates. Invest. Ophthalmol. Vis. Sci. 40:1999;2299-2306.
7. Cazevieille C., Osborne N.N. Retinal neurones containing kainate receptors are influenced by exogenous kainate and ischaemia while neurones lacking these receptors are not - melatonin counteracts the effects of ischaemia and kainate. Brain Res. 755:1997;91-100.
8. + channels: comparison with other β-adrenoceptor antagonists, Br. J. Pharmacol. 2000 (in press).
9. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
10. Gao H., Hollyfield J.G., Jolkkonen J., Puurunen K., Koistinaho J., Kauppinen R., Haapalinna A., Nieminen L., Sivenius J. Basic fibroblast growth factor: increased gene expression in inherited and light-induced photoreceptor degeneration. Exp. Eye Res. 62:1996;181-189.
11. Gotz M.E., Kunig G., Riederer P., Youdim M.B. Oxidative stress: free radical production in neural degeneration. Pharmacol. Ther. 63:1994;37-122.
12. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo? Free Radic. Res. 25:1996;439-454.
13. Hicks D., Heidinger V., Mohand Said S., Sahel J., Dreyfus H. Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischaemia. Gen. Pharmacol. 30:1998;265-273.
14. Hunter A.J. Calcium antagonists: their role in neuroprotection. Int. Rev. Neurobiol. 40:1997;95-108.
15. Jolkkonen J., Puurunen K., Koistinaho J., Kauppinen R., Haapalinna A., Nieminen L., Sivenius J. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischaemia. Eur. J. Pharmacol. 372:1999;31-36.
16. 2+ channel antagonists and neuroprotection from cerebral ischaemia. Eur. J. Pharmacol. 363:1998;1-15.
17. Kuhmonen J., Pokorny J., Miettinen R., Haapalinna A., Jolkkonen J., Riekkinen P. Sr., Sivenius J. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischaemia. Anesthesiology. 87:1997;371-377.
18. Langer S.Z., Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32:1980;337-362.
19. LeBel C.P., Bondy S.C. Persistent protein damage despite reduced oxygen radical formation in the aging rat brain. Int. J. Dev. Neurosci. 9:1991;139-146.
20. LeBel C.P., Ali S.F., McKee M., Bondy S.C. Organometal-induced increases in oxygen reactive species: the potential of 2′,7′-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol. Appl. Pharmacol. 104:1990;17-24.
21. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:1999;A7-14.
22. Livingston A., Low J., Morris B. Effects of clonidine and xylazine on body temperature in the rat. Br. J. Pharmacol. 81:1984;189-193.
23. Maier C., Steinberg G.K., Sun G.H., Zhi G.T., Maze M. Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischaemia. Anesthesiology. 79:1993;306-312.
24. Melena J., Wood J.P.M., Osborne N.N. Betaxolol, a beta-1-adrenoceptor antagonist, has an affinity for L-type Ca(2+) channels. Eur. J. Pharmacol. 378:1999;317-322.
25. Narahashi T., Huang C.S., Song J.H., Yeh J.Z. Ion channels as targets for neuroprotective agents. Ann. NY Acad. Sci. 825:1997;380-388.
26. M.S. Nash, J.P.M. Wood, J. Melena and N.N. Osborne, Flupirtine ameliorates ischaemic-like death of rat retinal ganglion cells by preventing calcium influx, Brain Res. 2000 (in press).
27. Nash M.S., Osborne N.N. Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest. Ophthalmol. Vis. Sci. 40:1999;1293-1298.
28. Neufeld A.H., Sawada A., Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. USA. 96:1999;9944-9948.
29. +-channel down-modulation versus presynaptic glutamate release inhibition. Rev. Neurosci. 9:1998;203-211.
30. Olney J.W. Excitotoxic amino acids and neuropsychiatric disorders. Annu. Rev. Pharmacol. Toxicol. 30:1990;47-71.
31. Osborne N.N. Binding of (-)[(3)H]noradrenaline to bovine membrane of the retina. Evidence for the existence of alpha-2-receptors. Vis. Res. 22:1982;1401-1407.
32. Osborne N.N. Inhibition of cAMP production by alpha-2-adrenoceptor stimulation in rabbit retina. Brain Res. 553:1991;84-88.
33. Osborne N.N., Herrera A.J. The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina. Neuroscience. 59:1994;1071-1081.
34. Osborne N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P.M., Nash M.S. Neuroprotection in relation to retinal ischaemia and relevance to glaucoma. Surv. Ophthalmol. 43:1999;S102-S128.
35. Osborne N.N., Wood J.P.M., Chidlow G., Bae J.H., Melena J., Nash M.S. Ganglion cell death in glaucoma: What do we really know? Br. J. Ophthalmol. 83:1999;980-986.
36. Osborne N.N., Chidlow G., Nash M.S., Wood J.P.M. The potential of neuroprotection in glaucoma treatment. Curr. Opin. Ophthalmol. 10:1999;82-92.
37. Osborne N.N., Cazevieille C., Carvalho A.L., Larsen A.K., DeSantis L. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res. 751:1997;113-123.
38. Osborne N.N., DeSantis L., Bae J.H., Ugarte M., Wood J.P.M., Nash M.S., Chidlow G. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp. Eye Res. 69:1999;331-342.
39. Osborne N.N., Pergande G., Block F., Schwarz M. Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocysteic acid-induced release of GABA in the rabbit retina. Brain Res. 667:1994;291-294.
40. Osborne N.N., Schwarz M., Pergande G. Protection of rabbit retina from ischemic injury by flupirtine. Invest. Ophthalmol. Vis. Sci. 37:1996;274-280.
41. Osborne N.N., DeSantis L., Melena J., Chidlow G., Wood J.P.M. Attenuation of ganglion cell dysfunction: A goal for glaucoma treatment in the new millennium. Ophthalmol. Clin. North Am. 13:2000;p123-30.
42. Osborne N.N., Cazevieille C., Wood J.P., Nash M.S., Pergande G., Block F., Kosinski C., Schwarz M. Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist. Gen. Pharmacol. 30:1998;255-263.
43. Peng M., Li Y., Luo Z., Liu C., Laties A.M., Wen R. Alpha2-adrenergic agonists selectively activate extracellular signal-regulated kinases in Muller cells in vivo. Invest. Ophthalmol. Vis. Sci. 39:1998;1721-1726.
44. Rego A.C., Santos M.S., Oliveira C.R. Influence of the antioxidants vitamin E and idebenone on retinal cell injury mediated by chemical ischaemia, hypoglycemia, or oxidative stress. Free Radic. Biol. Med. 26:1999;1405-1417.
45. Reis D.J., Regunathan S., Meeley M.P. Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion. Am. J. Hypertens. 5:1992;51s-57s.
46. Romanovsky A.A., Shido O., Ungar A.L., Blatteis C.M. Genesis of biphasic thermal response to intrapreoptically microinjected clonidine. Brain Res. Bull. 31:1993;509-513.
47. Shimidzu T., Itoh Y., Tatsumi S., Hayashi S., Ukai Y., Yoshikuni Y., Kimura K. Blockade of voltage-sensitive sodium channels by NS-7, a novel neuroprotective compound, in the rat brain. Naunyn Schmiedeberg's Arch. Pharmacol. 355:1997;601-608.
48. Siesjo B.K. Pathophysiology and treatment of focal cerebral ischaemia. Part I. Pathophysiology. J. Neurosurg. 77:1992;169-184.
49. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid [published erratum appears in Anal Biochem 1987 May 15;163(1):279]. Anal. Biochem. 150:1985;76-85.
50. Szabo M.E., Droy Lefaix M.T., Doly M., Braquet P. Ischaemia- and reperfusion-induced Na+, K+, Ca2+ and Mg2+ shifts in rat retina: effects of two free radical scavengers, SOD and EGB 761. Exp. Eye Res. 55:1992;39-45.
51. Talke P., Bickler P.E., Lee J.M., Zipfel G.J., Choi D.W. Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology. 85:1996;551-557.
52. Unoki K., LaVail M.M. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest. Ophthalmol. Vis. Sci. 35:1994;907-915.
53. Venkataraman V., Duda T., Galoian K., Sharma R.K. Molecular and pharmacological identity of the a(2D)-adrenergic receptor subtype in bovine retina and its photoreceptors. Mol. Cell. Biochem. 159:1996;129-138.
54. Wen R., Cheng T., Li Y., Cao W., Steinberg R.H. Alpha-2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J. Neurosci. 16:1996;5986-5992.
55. Wheeler L.A., Lai R., Woldemussie E. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. Eur. J. Ophthalmol. 9:(Suppl. 1):1999;S17-21.
56. Wikberg Matsson A., Wikberg J.E.S., Uhlen S. Characterization of alpha-2-adrenoceptor subtypes in the porcine eye: Identification of alpha (2A)-adrenoceptors in the choroid, ciliary body and iris, and alpha (2A)- and alpha (2C)-adrenoceptors in the retina. Exp. Eye Res. 63:1996;57-66.
57. Yoles E., Wheeler L.A., Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest. Ophthalmol. Vis. Sci. 40:1999;65-73.
58. Zhang C., Takahashi K., Lam T.T., Tso M.O.M. Effects of basic fibroblast growth factor in retinal ischaemia. Invest. Ophthalmol. Vis. Sci. 35:1994;3163-3168.